*  Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative...
Genetic and Rare Diseases Information Center resources: Homologous Wasting Disease Acute Graft Versus Host Disease ... This phase II trial studies donor atorvastatin treatment for the prevention of severe acute graft-versus-host disease (GVHD) in ... Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative ... Disease-free Survival [ Time Frame: 1 year after transplant ]. Evaluated as Kaplan-Meier estimate in the patients/recipients. ...
  https://clinicaltrials.gov/ct2/show/NCT01525407?recr=Open&cond=%22Testicular+Neoplasms%22&rank=6
*  Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease - Full Text View - ClinicalTrials.gov
Genetic and Rare Diseases Information Center resources: Homologous Wasting Disease Chronic Graft Versus Host Disease ... Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease. This study has been terminated. ... It occurs when the donor immune cells (the 'graft') attack and damage organs and tissue (the 'host'). It is thought that T ... Study to Assess the Safety and Efficacy of Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease. ...
  https://clinicaltrials.gov/ct2/show/NCT01226420?term=Farber
*  Frontiers | Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease | Immunology
Chronic graft-versus-host disease (cGVHD) is a debilitating complication arising in around half of all patients treated with an ... Chronic graft-versus-host disease (cGVHD) is a debilitating complication arising in around half of all patients treated with an ... APRIL levels are associated with disease activity in human chronic graft-versus-host disease. Haematologica (2016) 101(7):e312- ... ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med (2013) 369(6):529-39. doi: ...
  https://www.frontiersin.org/articles/10.3389/fimmu.2017.00717/full
*  REVERSE 1 INCB 18424-271 | Aplastic Anemia and MDS International Foundation
... in combination with corticosteroids in subjects with Grades II to IV steroid-refractory acute graft-versus-host disease (GVHD). ... Phase 2 Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus- ... Host Disease - The purpose of this study is to assess the efficacy of ruxolitinib ... Refractory Acute Graft-Versus-Host Disease - The purpose of this study is to assess the efficacy of ruxolitinib in combination ...
  http://www.aamds.org/treatments/clinical-trials/reverse-1-incb-18424-271
*  Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation - Full Text...
Graft vs Host Disease. Immune System Diseases. Methotrexate. Tacrolimus. Thymoglobulin. Antilymphocyte Serum. Abortifacient ... Graft Versus Host Disease Drug: Visilizumab Drug: Tacrolimus Drug: Methotrexate Drug: Antithymocyte globulin (ATG) Phase 2 ... graft versus host disease. GVHD. allogeneic transplant. GVHD prevention. unrelated donors. mismatched unrelated donors. ... Number of Participants With Grade II-IV Acute Graft-versus-Host Disease (GVHD) Score at 100 Days [ Time Frame: 100 days ]. ...
  https://clinicaltrials.gov/ct2/show/NCT00720629
*  Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral...
Lymphatic Diseases. Immunoproliferative Disorders. Immune System Diseases. Bone Marrow Diseases. Hematologic Diseases. ... Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral ... This randomized phase III trial studies how well graft-vs-host disease (GVHD) prophylaxis works in treating patients with ... Patients with clinical or laboratory evidence of liver disease would be evaluated for the cause of liver disease, its clinical ...
  https://clinicaltrials.gov/ct2/show/NCT01231412?recr=Open&cond=%22Myeloproliferative+Disorders%22&rank=20
*  Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral...
Lymphatic Diseases. Immunoproliferative Disorders. Immune System Diseases. Bone Marrow Diseases. Hematologic Diseases. ... Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral ... This randomized phase III trial studies how well graft-vs-host disease (GVHD) prophylaxis works in treating patients with ... Acute Graft Versus Host Disease Chronic Myeloid Leukemia Chronic Myeloproliferative Disorders Mantle Cell Lymphoma Leukemia, T- ...
  https://clinicaltrials.gov/ct2/show/NCT01231412?recr=Open&cond=%22Leukemia%2C+Myelogenous%2C+Chronic%2C+BCR-ABL+Positive%22&rank=14
*  Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood...
Homologous Wasting Disease Acute Lymphoblastic Leukemia Acute Graft Versus Host Disease Myeloid Leukemia Acute Myeloid Leukemia ... Rate of grade II-IV acute graft versus host disease (GVHD) in human leukocyte antigen (HLA) class I or II mismatched ... Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood ... cyclosporine and mycophenolate mofetil works in preventing graft-vs-host disease (GVHD) in patients with blood cancer ...
  https://clinicaltrials.gov/ct2/show/NCT01251575?recr=Open&cond=%22Leukemia%2C+Lymphoid%22&rank=19
*  Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral...
Homologous Wasting Disease Hodgkin Lymphoma Acute Graft Versus Host Disease Chronic Myeloid Leukemia Chronic Lymphocytic ... Lymphatic Diseases. Immunoproliferative Disorders. Immune System Diseases. Bone Marrow Diseases. Hematologic Diseases. ... Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral ... This randomized phase III trial studies how well graft-vs-host disease (GVHD) prophylaxis works in treating patients with ...
  https://clinicaltrials.gov/ct2/show/NCT01231412?cond=%22Lymphoma%2C+Non-Hodgkin%22&rank=19
*  Graft-versus-Host Diseases can Be Predicted
Two papers published this week investigate how graft versus host disease might be predicted after hematopoietic cell ... Graft-versus-host disease occurs when white blood cells from the donor attack tissues of the recipient. It is a very serious ... Graft-versus-host disease is a complication of allogeneic hematopoietic cell transplantation, which results from recognition of ... In the first paper "Prediction of Graft-Versus-Host Disease by Gene-Expression Profiling of Donors" Claude Perreault and ...
  http://www.medindia.net/news/view_news_main.asp?x=18005
*  Chronic graft-versus-host disease - Cancer Therapy Advisor
Chronic graft-versus-host disease What every physician needs to know:. Chronic graft-vs-host disease (GVHD) is a multisystem ... "Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to ... "Recognizing and managing chronic graft-versus-host disease". Hematology Am Soc Hematol Educ Program. 2008. pp. 134-141. ... "Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone ...
  http://www.cancertherapyadvisor.com/oncology/chronic-graft-versus-host-disease/article/619174/
*  Acute Graft-Versus-Host Disease Prognosis: Are Biomarkers Ready for Preemptive Clinical Trials? | Clinical Chemistry
Acute Graft-Versus-Host Disease Prognosis: Are Biomarkers Ready for Preemptive Clinical Trials?. Sophie Paczesny ... Acute Graft-Versus-Host Disease Prognosis: Are Biomarkers Ready for Preemptive Clinical Trials? ... Acute Graft-Versus-Host Disease Prognosis: Are Biomarkers Ready for Preemptive Clinical Trials? ... and posttransplant graft-versus-host disease (GVHD) prophylaxis, they incompletely predict results. Biomarkers promise to ...
  http://clinchem.aaccjnls.org/content/63/10/1561
*  Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease...
Graft vs Host Disease. Immune System Diseases. Cyclophosphamide. Tacrolimus. Fludarabine phosphate. Cytarabine. Fludarabine. ... Graft-Versus-Host-Disease. LLME. CD34+ stem cell infusions. CD34- fraction. Cyclosporine. Mycophenolate Mofetil. HSCT. ... Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease ... Incidence of Grade II-IV Acute Graft-Versus-Host-Disease (GVHD) [ Time Frame: Through 24 months post-treatment ]. Determine the ...
  https://clinicaltrials.gov/show/NCT00429416
*  Transfusion-associated graft versus host disease - Wikipedia
Transfusion-associated graft-versus-host disease (TA-GvHD) is a rare complication of blood transfusion, in which the donor T ... Full text Gupta, A; Bansal, D; Dass, R; Das, A (2004). "Transfusion Associated Graft versus Host Disease". Indian Pediatr. 41 ( ... Anwar M, Bhatti F (2003). "Transfusion associated graft versus host disease". J Ayub Med Coll Abbottabad. 15 (3): 56-8. PMID ... This can result in graft-versus-host disease. The incidence of TA-GvHD in immunocompromised patients receiving blood ...
  https://en.wikipedia.org/wiki/Transfusion-associated_graft_versus_host_disease
*  Vaginal graft verse host disease - Cancer - MedHelp
Vaginal graft verse host disease. Hi I'm a female 18 years old who had an Allogenic Bone Marrow Transplant at 17 as I was ... I've been dealing with Graft Verse Host Disease and it has been affecting my vaginal region. It has been very tight and sore ... I've been dealing with Graft Verse Host Disease and it has been affecting my vaginal region. It has been very tight and sore ... New cervical cancer screening guidelines change when and how women should be tested for the disease. ...
  http://www.medhelp.org/posts/Cancer/Vaginal-graft-verse-host-disease/show/1877392
*  Deltasone User Reviews for Graft-versus-host disease at Drugs.com
Reviews and ratings for deltasone when used in the treatment of graft-versus-host disease. Share your experience with this ... Reviews for Deltasone to treat Graft-versus-host disease. No reviews have yet been submitted. Be the first to review this drug. ...
  https://www.drugs.com/comments/prednisone/deltasone-for-graft-versus-host-disease.html
*  How we treat chronic graft-versus-host disease | Blood Journal
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or ... Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to ... Front line treatment of chronic graft versus host disease. In: Vogelsang GB, Pavletic SZ, editors. Chronic Graft Versus Host ... Emerging strategies in the treatment of chronic graft-versus-host disease: traditional treatment of chronic graft-versus-host ...
  http://www.bloodjournal.org/content/125/4/606?sso-checked=true
*  Non-Coding RNAs and Graft versus Host Disease | Frontiers Research Topic
Pro-inflammatory pathways that become activated during graft-versus-host disease (GVHD) are regulated in part by microRNAs ( ... Keywords: Non-coding RNAs, microRNAs, Graft versus host disease, GVHD Important Note: All contributions to this Research Topic ... Pro-inflammatory pathways that become activated during graft-versus-host disease (GVHD) are regulated in part by microRNAs ( ... Pro-inflammatory pathways that become activated during graft-versus-host disease (GVHD) are regulated in part by microRNAs ( ...
  https://www.frontiersin.org/research-topics/6779/non-coding-rnas-and-graft-versus-host-disease
*  Clobetasol for Oral Graft-Versus-Host Disease - Full Text View - ClinicalTrials.gov
Genetic and Rare Diseases Information Center resources: Homologous Wasting Disease Chronic Graft Versus Host Disease ... Condition or disease Intervention/treatment Phase Oral Chronic Graft vs Host Disease Drug: Clobetasol Oral Rinse Drug: Placebo ... Graft vs Host Disease. Immune System Diseases. Clobetasol. Anti-Inflammatory Agents. Glucocorticoids. Hormones. Hormones, ... Clobetasol for Oral Graft-Versus-Host Disease. The safety and scientific validity of this study is the responsibility of the ...
  https://clinicaltrials.gov/ct2/show/NCT01557517?recr=Open&intr=%22Oral+Health%22&rank=9
*  Chronic graft-versus-host disease
D89.811 - Chronic graft-versus-host disease. SNOMEDCT:. 402356004 - Chronic graft-versus-host disease. Look For. Subscription ... Chronic graft-versus-host disease. Subscriber Sign In VisualDx Mobile Feedback Select Language Share ... Chronic graft-versus-host disease in Infant/Neonate. See also in: Nail and Distal Digit,Oral Mucosal Lesion. Print Images (7) ... Graft-versus-host disease (GVHD) refers to organ dysfunction resulting from the introduction of foreign immunocompetent ...
  https://www.visualdx.com/visualdx/diagnosis/chronic%20graft-versus-host%20disease?diagnosisId=51629&moduleId=103
*  Extracorporeal Photopheresis for Acute Graft Versus Host Disease - Full Text View - ClinicalTrials.gov
Genetic and Rare Diseases Information Center resources: Homologous Wasting Disease Acute Graft Versus Host Disease ... Condition or disease Intervention/treatment Phase Graft Versus Host Disease Cancer Stem Cell Transplantation Procedure: ... Extracorporeal Photopheresis for Acute Graft Versus Host Disease. The safety and scientific validity of this study is the ... in the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in children. [ Time Frame: To end of study ]. *To ...
  https://clinicaltrials.gov/ct2/show/NCT00179855
*  B cell survival holds key to chronic graft vs. host disease | EurekAlert! Science News
... identifying a promising target for developing new therapies for the diseases. ... the laboratory that B cells from patients with chronic GVHD are much more active than cells from patients without the disease. ... In chronic Graft vs. Host Disease (GVHD), the differences between the donor bone marrow cells and the recipient's body often ... B cell survival holds key to chronic graft vs. host disease. University of North Carolina Health Care ...
  https://www.eurekalert.org/pub_releases/2012-08/uonc-bcs081612.php
*  TREATING GRAFT-VERSUS-HOST DISEASE OCULAR SURFACE COMPLICATIONS IN A PEDIATRIC POPULATION
... Jamie Weiser ... It is essential for eye care practitioners to manage ocular sequelae of graft-versus-host disease in children and throughout ... Hematopoietic stem cell transplantation is the current standard of care treatment for childhood hematologic diseases. ...
  https://www.aaopt.org/detail/knowledge-base-article/treating-graft-versus-host-disease-ocular-surface-complications-pediatric-population
*  Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body...
I. To estimate the incidence of grade III/IV graft-versus-host disease (GVHD) after conditioning with 200 centigray (cGy) TBI ... This phase II trial studies how well tacrolimus and mycophenolate mofetil works in preventing graft-versus-host disease in ... Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body ... Incidences of Graft Rejection [ Time Frame: Day 180 post-transplantation ]. Number of patients who rejected their graft. ...
  https://clinicaltrials.gov/ct2/show/NCT00089011?recr=Open&cond=%22Mycoses%22&rank=3